The introduction of teprotumumab for the treatment of thyroid eye disease has dramatically improved management of this life-changing condition; however, clinical trials and experience in the clinic have revealed associated hearing abnormalities.

中文翻译：

---

替普罗妥尤单抗治疗患者的听力异常

用于治疗甲状腺眼病的 teprotumumab 的引入极大地改善了这种改变生活的疾病的治疗；然而，临床试验和临床经验表明存在相关的听力异常。